<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365737">
  <stage>Registered</stage>
  <submitdate>4/03/2014</submitdate>
  <approvaldate>25/03/2014</approvaldate>
  <actrnumber>ACTRN12614000318684</actrnumber>
  <trial_identification>
    <studytitle>Evaluation of radiographic and clinical outcomes following  Absolut femoral prosthesis and Global acetabular cup total hip replacement surgery</studytitle>
    <scientifictitle>Clinical and Radiological Outcome using the Absolut femoral prosthesis and the Global cup system following total hip arthroplasty in patients with Degenerative Joint Disease</scientifictitle>
    <utrn />
    <trialacronym>AGC-COP13S</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Degenerative Joint Disease</healthcondition>
    <healthcondition>primary Total Hip Arthroplasty</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Prospective study evaluating post-operative radiology and clinical outcomes in patients who undergo primary total hip replacement using the Absolut femoral stem and Global acetabular cup.

Patients will be recruited over a 2 year period and followed up to 10 years after surgery.

Duration of surgery will be as is standard for total hip arthroplasty.</interventions>
    <comparator>n/a</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To evaluate the performance of the Absolut cemented femoral stem with the Global acetabular cup. Patient clinical and radiolographic outcomes will be analysed through 10 years post surgery.</outcome>
      <timepoint>Pre-operative, post-operative, 6 weeks, 12 month, 2, 5 and 10 years</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient Quality of Life questionnaires, clinical and functional evaluation.

The measurement tools will be:
Assessment of Quality of Life AQoL 6D - a descriptive system of health-related quality of life statements consisting of six dimensions (Independent Living, Mental Health, Coping, Relationships, Pain, Senses) with variable item numbers and response levels.

Oxford Hip - a disease specific assessment tool that evaluates pain, symptoms and function.

Pain Visual Analogue Scale (VAS) - a tool that monitors the patients own perception of their pain and its severity.</outcome>
      <timepoint>Pre-operative and post-operative at  6 weeks, 12 months, 2, 5, 10 years</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>The individual is diagnosed with a primary diagnosis of Degenerative Joint Disease.</inclusivecriteria>
    <inclusiveminage>60</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-The individual has an active infection within the affected hip joint.
-The individual has had previous total hip replacement or hip fusion of the affected hip joint.
-The individual has a neuromuscular or neurosensory deficit which limits the ability to evaluate safety and effectiveness of the device or has a systemic disease that would affect the subject's welfare or overall outcome of the study.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>26/03/2014</anticipatedstartdate>
    <actualstartdate>20/05/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>150</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
    <hospital>Fremantle Hospital and Health Service - Fremantle</hospital>
    <hospital>Rockingham General Hospital - Cooloongup</hospital>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Global Orthopaedic Technology Pty Ltd</primarysponsorname>
    <primarysponsoraddress>Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Global Orthopaedic Technology Pty Ltd</fundingname>
      <fundingaddress>Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Fixation of the femoral stem and acetabular shell in their respective bones can be with cement, specialised coatings or a combination of the two (i.e. stem in cement, acetabulum with porous coating), known as hybrid fixation.  The cemented Absolut hip stem with the non-cemented Global acetabular cup will be evaluated following primary total hip replacement surgery.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>South Metropolitan Health Service HREC- WA</ethicname>
      <ethicaddress>Fremantle Hospital. PO 480 Fremantle WA 6959</ethicaddress>
      <ethicapprovaldate>19/12/2013</ethicapprovaldate>
      <hrec>SMHS HREC Ref: 12/239</hrec>
      <ethicsubmitdate>5/08/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Piers Yates</name>
      <address>Department of Orthopaedic Surgery
Fremantle Hospital,
Alma Street
Fremantle
PO Box 480, WA 6959
</address>
      <phone>+61 8 9431 2260</phone>
      <fax />
      <email>piers.yates@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Lyndon Crossley</name>
      <address>Global Orthopaedic Technology
Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</address>
      <phone>+61 2 8887 0115</phone>
      <fax />
      <email>lyndon@globalortho.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Lyndon Crossley</name>
      <address>Global Orthopaedic Technology
Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</address>
      <phone>+61 2 8887 0115</phone>
      <fax />
      <email>lyndon@globalortho.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Lyndon Crossley</name>
      <address>Global Orthopaedic Technology
Unit 10, 7 Meridian Place
Baulkham Hills, NSW 2153</address>
      <phone>+61 2 8887 0115</phone>
      <fax />
      <email>lyndon@globalortho.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>